Find details on advances in the management of type 1 diabetes, utilization of CGM in primary care settings, and optimizing T2D management in older persons.

Adults saying they don't need immunization this fall have received the vaccines in the past, survey authors report, suggesting a lingering misinformation effect.

Your daily dose of the clinical news you may have missed.

Erenumab 140 mg safely and effectively induced remission in nonopioid MOH within 6 months in individuals for whom other preventive medications had failed.

FluMist is the first influenza vaccine that does not have to be given by a health care professional.

The only CGM system cleared for 1 year of use in type 1 and 2 diabetes is expected to be available in the fourth quarter of this year, the manufacturers said.

New report includes data on the safety and immunogenicity of the recently-approved PCV21 vaccine.

Your daily dose of the clinical news you may have missed.

Immune responses for both vaccines were noninferior when given at the same visit compared with separate administration among adults aged 50 years and older.

The positive pivotal phase 3 trial results showed improved lung function with neradomilast vs placebo and will support BI's US and global NDA submissions.